These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Anti-angiogenic treatments in metastatic colorectal cancer: Does a continuous angiogenic blockade make sense?]. Jary M; Borg C; Bouché O; Kim S; André T; Bennouna J Bull Cancer; 2015 Sep; 102(9):758-71. PubMed ID: 26232849 [TBL] [Abstract][Full Text] [Related]
6. [Tumour angiogenesis inhibition by therapeutic monoclonal antibodies]. Cézé N; Lecomte T; Watier H Med Sci (Paris); 2009 Dec; 25(12):1099-104. PubMed ID: 20035685 [TBL] [Abstract][Full Text] [Related]
7. Targeting angiogenesis in oncology, ophthalmology and beyond. Cao Y; Langer R; Ferrara N Nat Rev Drug Discov; 2023 Jun; 22(6):476-495. PubMed ID: 37041221 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor: biology and therapeutic applications. Ho QT; Kuo CJ Int J Biochem Cell Biol; 2007; 39(7-8):1349-57. PubMed ID: 17537667 [TBL] [Abstract][Full Text] [Related]
9. A new weapon for attacking tumor blood vessels. Semenza GL N Engl J Med; 2008 May; 358(19):2066-7. PubMed ID: 18463385 [No Abstract] [Full Text] [Related]
10. Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration. Ng EW; Adamis AP Can J Ophthalmol; 2005 Jun; 40(3):352-68. PubMed ID: 15947805 [TBL] [Abstract][Full Text] [Related]
11. [New medications; bevacizumab]. Cohen AF; van Bronswijk H Ned Tijdschr Geneeskd; 2006 Oct; 150(40):2194-5. PubMed ID: 17061430 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies targeting vascular endothelial growth factor: current status and future challenges in cancer therapy. Hsu JY; Wakelee HA BioDrugs; 2009; 23(5):289-304. PubMed ID: 19754219 [TBL] [Abstract][Full Text] [Related]
13. Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease. Tolentino M Surv Ophthalmol; 2011; 56(2):95-113. PubMed ID: 21335144 [TBL] [Abstract][Full Text] [Related]
17. Playing only one instrument may be not enough: limitations and future of the antiangiogenic treatment of cancer. Quesada AR; Medina MA; Alba E Bioessays; 2007 Nov; 29(11):1159-68. PubMed ID: 17935210 [TBL] [Abstract][Full Text] [Related]
18. [Anti-angiogenic treatment and colorectal cancer]. André T; Tournigand C; Abbas F; Louvet C; de Gramont A; Bull Cancer; 2007 Jul; 94 Spec No():S211-9. PubMed ID: 17846007 [TBL] [Abstract][Full Text] [Related]